N¹,N¹-dimethylbenzene-1,3-disulfonamide | 101252-56-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N¹,N¹-dimethylbenzene-1,3-disulfonamide
• 英文别名: 3-Sulfamolyl-benzolsulfonsaeure-dimethylamid；5-Sulfamoyl-benzolsulfonsaeure-dimethylamid；Sulfamoylbenzol-3-sulfondimethylamid；N1,N1-dimethylbenzene-1,3-disulfonamide；3-N,3-N-dimethylbenzene-1,3-disulfonamide
• CAS: 101252-56-6
• 化学式: C₈H₁₂N₂O₄S₂
• mdl: MFCD11204994
• 分子量: 264.326
• InChiKey: CBYXUTXXLSLJIU-UHFFFAOYSA-N

物化性质

• 熔点：
  177-178 °C
• 沸点：
  473.7±55.0 °C(Predicted)
• 密度：
  1.437±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  114
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  N¹,N¹-dimethylbenzene-1,3-disulfonamide 、 环己基异氰酸酯 在 sodium hydroxide 作用下， 以 丙酮 为溶剂， 生成
  参考文献：
  名称：

  Hypoglycaemic Agents. Part II

  摘要：

  描述了在芳香核中取代的1-苯磺酰基-3-丁基（或环己基）脲的各种衍生物。

  DOI：

  10.1111/j.2042-7158.1962.tb11123.x

文献信息

• Diepoxide derivatives of N, N*-disubstituted disulfonamides
  申请人：Pews Garth R.

  公开号：US20060128978A1

  公开（公告）日：2006-06-15

  The present invention relates to novel diepoxides having the formulas I. and II. R*N(A)SO 2 RSO 2 N(A)R*  I R*SO 2 N(A)RN(A)SO 2 R*  II where A=2,3-epoxypropyl, R* is a monovalent hydrocarbon alkyl aryl, aryl-alkyl, alkyl-aryl radical of 1-20 carbon atoms or a monovalent inertly substituted hydrocarbon aryl, alkyl, alkyl-aryl or aryl-alkyl radical of 1-20 carbons atoms and R is a divalent hydrocarbon arylene, alkylene, alkylene-aryl, arylene-alkyl radical or combinations thereof of 2-20 carbon atoms or an inertly substituted divalent hydrocarbon alkylene, arylene, arylene-alkyl, or alkylene-aryl radical or combinations thereof of 2-20 carbon atoms. The epoxides are useful in preparing novel epoxide resins.

  本发明涉及具有以下化学式的新型双环氧化物：I. 和 II. R*N(A)SO2RSO2N(A)R*  I R*SO2N(A)RN(A)SO2R*  II其中 A=2,3-环氧丙基，R* 是具有 1-20 个碳原子的一价碳氢烷基芳基、芳基-烷基、烷基-芳基或一价惰性取代的碳氢烷基芳基、烷基、烷基-芳基或芳基-烷基基团，R 是具有 2-20 个碳原子的二价碳氢芳基、烷基、烷基-芳基、芳基-烷基基团或其组合，或具有 2-20 个碳原子的惰性取代的二价碳氢烷基、芳基、芳基-烷基或烷基-芳基基团或其组合。这些环氧化物可用于制备新型环氧树脂。
• [EN] SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME<br/>[FR] SULFONYLURÉES ET COMPOSÉS APPARENTÉS ET LEUR UTILISATION
  申请人：UNIV QUEENSLAND

  公开号：WO2017140778A1

  公开（公告）日：2017-08-24

  The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts, solvates and prodrugs thereof: Formula (I) wherein Q is selected from O, S and Se; J is S or Se; W1 and W2, when present, are independently selected from N and C; R1 and R2 are independently selected from the group consisting of hydrogen, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, aryl, heterocyclyl, heteroaryl, cycloalkyl, cycloalkenyl, amino, amido, alkylthio, acyl, arylalkyl and acylamido, all of which may be optionally substituted; and wherein at least one of W1 and W2 is present and is a nitrogen atom and when R1 and R2 are cyclic then the respective W1 or W2 may form part of the ring structure. The present invention also relates to pharmaceutical compositions including such compounds, to methods of treatment using such compounds, in particular in relation to NLRP3 inflammasome mediated disorders, and to associated diagnostic uses.

  本发明涉及化合物的公式（I），以及其药学上可接受的盐、溶剂化合物和前药：公式（I）其中Q从O、S和Se中选择；J为S或Se；当存在时，W1和W2独立地从N和C中选择；R1和R2独立地从氢、C1-C12烷基、C2-C12烯基、C2-C12炔基、芳基、杂环烷基、杂芳基、环烷基、环烯基、氨基、酰胺基、烷基硫基、酰基、芳基烷基和酰胺基中选择，其中所有这些基团可能是可选地取代的；其中W1和W2中至少有一个存在且为氮原子，当R1和R2为环时，相应的W1或W2可能构成环结构的一部分。本发明还涉及包括这些化合物的药物组合物，使用这些化合物的治疗方法，特别是与NLRP3炎症小体介导的疾病相关的治疗方法，以及相关的诊断用途。
• Novel condensation polymers from N, N*-disubstituted disulfonamides
  申请人：Pews Garth R.

  公开号：US20060128924A1

  公开（公告）日：2006-06-15

  The present invention relates to novel condensation polymers where N,N*-disubstituted disulfonamides are copolymerized with an organic acid dihalide such as dicarboxylic acid dichlorides, disulfonic acid dichlorides, bis chloroformates, diphosphoryl acid dichlorides, diphosphonyl acid dichlorides, or phosgene or with diisocyanates. The polymers obtained are thermoplastic and useful in molding and extrusion application.

  本发明涉及新型缩聚聚合物，其中N，N* -二取代二磺酰胺与有机酸二卤代物（如二羧酸二氯化物，二磺酸二氯化物，双氯甲酸酯，二磷酸二氯化物，二膦酸二氯化物或光气）或二异氰酸酯共聚。所得到的聚合物是热塑性的，可用于模塑和挤出应用。
• N-(PHENYLSULFONYL) PICOLINAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND HERBICIDE
  申请人：KUREHA KAGAKU KOGYO KABUSHIKI KAISHA

  公开号：EP1069112A1

  公开（公告）日：2001-01-17

  A herbicide comprising as the active ingredient an N-(phenylsulfonyl)picolinamide derivative represented by the following general formula. This ingredient is synthesized by condensing a substituted picolinic acid with a substituted benzenesulfonamide or reacting a substituted picolinic phenyl ester with a substituted benzenesulfonamide in the presence of a basic compound: wherein X represents halogen atom, C1-C4 alkyl group, C1-C4 haloalkyl group, C1-C4 alkoxy group, C1-C4 haloalkoxy group, (C1-C4 alkoxy)carbonyl group, (di-C1-C4 alkylamino)sulfonyl group, [N-(C1-C4 alkyl)-N-(C1-C4 alkoxy)amino]sulfonyl group, (C1-C4 alkylamino)sulfonyl group, C1-C4 alkylthio group, C1-C4 alkylsulfinyl group, C1-C4 alkylsulfonyl group or nitro group, n is an integer of 0 - 5, Y represents halogen atom, C1-C4 alkyl group, C1-C4 haloalkyl group, C1-C4 alkoxy group, C1-C4 haloalkoxy group, C1-C4 alkylthio group, C1-C4 haloalkylthio group, amino group, C1-C4 alkylamino group, di-C1-C4 alkylamino group, (C1-C4 alkoxy) C1-C4 alkyl group, (C1-C4 alkylthio) C1-C4 alkyl group or nitro group, m is an integer of 0 - 4.

  一种除草剂，其活性成分为由下式通式表示的 N-(苯磺酰基)吡啶酰胺衍生物。这种成分是通过将取代的吡啶甲酸与取代的苯磺酰胺缩合或将取代的吡啶苯基酯与取代的苯磺酰胺在碱性化合物存在下反应而合成的： 其中 X 代表卤素原子、C1-C4 烷基、C1-C4 卤代烷基、C1-C4 烷氧基、C1-C4 卤代烷氧基、(C1-C4 烷氧基)羰基、(二-C1-C4 烷基氨基)磺酰基、[N-(C1-C4 烷基)-N-(C1-C4 烷氧基)氨基]磺酰基、(C1-C4 烷基氨基)磺酰基、C1-C4 烷硫基、C1-C4 烷基亚磺酰基、C1-C4 烷基磺酰基或硝基，n 为 0-5 的整数、 Y 代表卤素原子、C1-C4 烷基、C1-C4 卤代烷基、C1-C4 烷氧基、C1-C4 卤代烷氧基、C1-C4 烷硫基、C1-C4 卤代烷硫基、氨基、C1-C4 烷基氨基、二 C1-C4 烷基氨基、(C1-C4 烷氧基) C1-C4 烷基、(C1-C4 烷硫基) C1-C4 烷基或硝基、 m 是 0 - 4 的整数。
• 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives
  申请人：PFIZER INC.

  公开号：EP1270565A1

  公开（公告）日：2003-01-02

  The invention relates to a compound, 4-(1-hydroxy-1-methyl-ethyl)furan-2-sulfonamide, and its use as an intermediate in the preparation of a compound of the formula wherein R1 and R2 are as defined in the description, useful in the treatment and condition selected from the group consisting of meningitis and salpingitis, septic shock, disseminated intravascular coagulation, and/or adult respiratory distress syndrome, acute or chronic inflammation, arthritis, cholangitis, colitis, encephalitis, endocarditis, glomerulonephritis, hepatitis, myocarditis, pancreatitis, pericarditis, reperfusion injury, vasculitis, acute and delayed hypersensitivity, graft rejection, and graft-versus-host disease, auto-immune diseases including Type 1 diabetes mellitus and multiple sclerosis, periodonate diseases, interstitial pulmonary fibrosis, cirrhosis, systemic sclerosis, keloid formation, tumors which produce IL-1 as an autocrine growth factor, cachexia, Alzheimers disease, percussion injury, depression, atherosclerosis (including cardiomyopathy, myocarditis and heart failure) and osteoporosis in a mammal, including a human.

  本发明涉及一种化合物，4-(1-羟基-1-甲基-乙基)呋喃-2-磺酰胺，及其在制备 式化合物中作为中间体的用途，其中 R1 和 R2 如描述中所定义。 其中 R1 和 R2 如描述中所定义，可用于治疗选自以下组别的疾病：脑膜炎和输卵管炎、脓毒性休克、弥散性血管内凝血和/或成人呼吸窘迫综合征、急性或慢性炎症、关节炎、胆管炎、结肠炎、脑炎、心内膜炎、肾小球肾炎、肝炎、心肌炎、胰腺炎、心包炎、再灌注损伤、血管炎、急性和迟发性超敏反应、移植物排斥和移植物抗宿主疾病、自身免疫性疾病（包括 1 型糖尿病和多发性硬化症）、牙周病、间质性肺纤维化、肝硬化、系统性硬化症、瘢痕疙瘩的形成、产生 IL-1 作为自分泌生长因子的肿瘤、恶病质、老年痴呆症、叩击伤、抑郁症、动脉粥样硬化（包括心肌病、心肌炎和心力衰竭）以及哺乳动物（包括人类）骨质疏松症。